The Functional Defects of Hereditary Dysfibrinogens

Victor J. Marder

doi:10.1055/s-0038-1648003

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1976; 36(01): 001-008
DOI: 10.1055/s-0038-1648003

Original Article

Schattauer GmbH

The Functional Defects of Hereditary Dysfibrinogens^[*]

Victor J. Marder

¹Department of Medicine and the Specialized Center of Research in Thrombosis, Temple University Health Sciences Center, Philadelphia, Pennsylvania

› Author Affiliations

Abstract

Full Text

References

References
1 Al-Mondhiry H. A. B, Bilezikian S. B, Nossel H. L. 1975; Fibrinogen ‘‘New York” — An abnormal fibrinogen associated with thromboembolism: Functional evaluation. Blood 45: 607.
2 Beck E. A, Charache P, Jackson D. P. 1965; A new inherited coagulation disorder caused by an abnormal fibrinogen (‘Fibrinogen Baltimore’). Nature 208: 143.
3 Beck E. A, Shainoff J. R, Vogel A, Jackson D. P. 1971; Functional evaluation of an inherited abnormal fibrinogen: Fibrinogen “Baltimore”. Journal of Clinical Investigation 50: 1874.
4 Blombäck B, Blombäck M. 1970; Molecular defects and variants of fibrinogen. Nouvelle Revue Française d’Hématologie 10: 671.
5 Blombäck B, Blombäck M, Henschen A, Hessel B, Iwanaga S, Woods k. R. 1968; N-terminal disulfide knot of human fibrinogen. Nature 218: 130.
6 Blombäck B, Vestermark A. 1958; Isolation of fibrino-peptides by chromatography. Arkiv Kemi 12: 173.
7 Blombäck B, Yamashina I. 1958; On the N-terminal amino acids in fibrinogen and fibrin. Arkiv Kemi 12: 299.
8 Blombäck M, Blombäck B, Mammen E. F, Prasad A. S. 1968; Fibrinogen Detroit - a molecular defect in the N-terminal disulphide knot of human fibrinogen?. Nature (London) 218: 134.
9 Brown C. H, Crowe M. F. 1975; Defective α-polymerization in the conversion of fibrinogen Baltimore to fibrin. Journal of Clinical Investigation 55: 1190.
10 Budzynski A. Z, Marder V. J. (in press): Plasmic degradation of fibrinogen Paris I. Journal of Laboratory and Clinical Medicine.
11 Budzynski A. Z, Marder V. J, Ménache D, Guillin M. C. 1974; Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I). Nature 252: 66.
12 Chen R, Doolittle R. F. 1971; γ — γ cross-linking sites in human and bovine fibrin. Biochemistry 10: 4486.
13 Crum E. D, Shainoff J. R, Graham R. C, Ratnoff O. D. 1974; Fibrinogen Cleveland II: An abnormal fibrinogen with defective release of fibrinopeptide A. Journal of Clinical Investigation 53: 1308.
14 Forman W. B, Ratnoff O. D, Boyer M. H. 1968; An inherited qualitative abnormality in plasma fibrinogen: Fibrinogen Cleveland. Journal of Laboratory and Clinical Medicine 72: 455.
15 Gaffney P. J, Brasher M. 1973; Subunit structure of the plasmin-induced degradation products of crosslinked fibrin. Biochimica Biophysica Acta 295: 308.
16 Gralnick H. R, Givelber H. M, Finlayson J. S. 1973; A new congenital abnormality of human fibrinogen. Fibrinogen Bethesda II. Thrombosis et Diathesis Haemorrhagica 29: 562.
17 Gralnick H. R, Givelber H. M, Shainoff J. R, Finlayson J. S. 1971; Fibrinogen Bethesda: A congenital dysfibrinogenemia with delayed fibrinopeptide release. Journal of Clinical Investigation 50: 1819.
18 Guillin M. C, Ménaché D. 1973; Fetal fibrinogen and fibrinogen Paris I: Comparative fibrin monomers aggregation studies. Thrombosis Research 3: 117.
19 Hasselback R, Marion R. B, Thomas J. W. 1963; Congenital hypofibrinogenemia in five members of a family. Canadian Medical Association Journal 88: 19.
20 Janssen C. L, Vreeken J. 1971; Fibrinogen Amsterdam, another hereditary abnormality of fibrinogen. British Journal of Haematology 20: 287.
21 Kopec M, Teisseyre E, Dudec-Wojciechowska G, Kloczewiak M, Pankiewicz A, Latallo Z.S. 1973; Studies on the “Double D” fragment from stabilized bovine fibrin. Thrombosis Research 2: 283.
22 Köppel G. 1966; Electron microscopic investigation of the shape of fibrinogen nodules: A model for certain protein. Nature 212: 1608.
23 Krause W. H, Heene D. L, Lasch H. G. 1973; Congenital dysfibrinogenemia (Fibrinogen Giessen). Thrombosis et Diathesis Haemorrhagica 29: 547.
24 Lacombe M, Soria J, Soria C, d’Angelo G, Lavallee R, Bonny Y. 1973; Fibrinogen Montreal. A new case of congenital dysfibrinogenemia with defective aggregation of monomers. Thrombosis et Diathesis Haemorrhagica 29: 536.
25 Mammen E. F, Prasad A. S, Barnhart M. I, Au C. C. 1969; Congenital dysfibrinogenemia: Fibrinogen Detroit. Journal of Clinical Investigation 48: 235.
26 Marder V. J, Budzynski A. Z. 1974; Fibrinogen and its derivatives, hereditary and acquired abnormalities. Schweizerische Medizinische Wochenschrift 104: 1338.
27 Marder V. J, Budzynski A. Z. 1975; Data for defining fibrinogen and its plasmic degradation products. Thrombosis et Diathesis Haemorrhagica 33: 199.
28 Marder V. J, Budzynski A. Z, Barlow G. H. 1976; Comparison of the physicochemical properties of Fragment D derivatives of fibrinogen and Fragment D-D of crosslinked fibrin. Biochimica Biophysica Acta 427: 1.
29 Marder V. J, Shulman N. R, Carroll W. R. 1967; The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. Transactions of the Association of American Physicians 53: 156.
30 Martinez J, Holburn R. R, Shapiro S. S, Erslev A. J. 1974; Fibrinogen Philadelphia: A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. Journal of Clinical Investigation 53: 600.
31 Ménahé D. Dysfibrinogenemie constitutionnelle et familiale. Proceedings of the 9th Congress of the European Society of Haematology, Lisbon 1963. S. Karger, Basel; New York: 1963: 1255.
32 Ménahé D. 1973; Abnormal fibrinogens. A review. Thrombosis et Diathesis Haemorrhagica 29: 525.
33 Mester L. 1968. Structure and possible role of the carbohydrate moiety in fibrinogen. In: Laki K. (ed.) Fibrinogen. Marcel Dekker, Inc.; New York: 165.
34 McKee P. A, Mattock P, Hill R. L. 1970; Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proceedings of the National Academy of Science 66: 738.
35 Mosesson M. W, Amrani D. L, Ménaché D. 1976; Studies on the structural abnormality of fibrinogen Paris I. Journal of Clinical Investigation 57: 782.
36 Mosesson M. W, Beck E. A. 1969; Chromatographic, ultracentrifugal and related studies of fibrinogen “Baltimore”. Journal of Clinical Investigation 48: 1656.
37 Pizzo S. V, Taylor Jr. L. M, Schwartz M. L, Hill R. L, McKee P. A. 1973; Subunit structure of Fragment D from fibrinogen and crosslinked fibrin. Journal of Biological Chemistry 248: 4584.
38 Pouit L, Marcille G, Suscillon M, Hollard D. 1972; Étude en microscopie électronique de differentes étapes de la fibrinoformation. Thrombosis et Diathesis Haemorrhagia 27: 559.
39 Samama M, Soria J, Soria C, Bousser J. 1969; Dysfibrinogénémie congénitale et familiale sans tendance hémorragique. Nouvelle Revue Française d’Hématologie 9: 817.
40 Shulman S. 1953; The size and shape of bovine fibrinogen. Studies of sedimentation, diffusion and viscosity. Journal of the American Chemical Society 75: 5846.
41 von Felten A, Duckert F, Frick P. G. 1966; Familial disturbance of fibrin monomer aggregation. British Journal of Haematology 12: 667.
42 von Felten A, Frick P. G, Straub P. W. 1969; Studies on fibrin monomer aggregation in congenital dysfibrinogenaemia (Fibrinogen ‘Zurich’): Separation of a pathological from a normal fibrin fraction. British Journal of Haematology 16: 353.

The Functional Defects of Hereditary Dysfibrinogens[*]

The Functional Defects of Hereditary Dysfibrinogens^[*]